Quanterix Corporation

Quanterix Corporation

Quanterix Corporation develops technologies to quantify biomarkers in ways that improved diagnostics and personalize health care.

Stock Performance Snapshot

Hold

Analyst Rating

Analysts suggest holding Quanterix stock with a target price of $20.33, indicating potential growth.

Above Average

Financial Health

Quanterix Corporation is performing well with strong revenue and cash flow, indicating good financial health.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring QTRX

Diagnostic Takeover Targets

Diagnostic Takeover Targets

This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.

Published: July 15, 2025

Explore Basket
Liquid-Biopsy Diagnostics

Liquid-Biopsy Diagnostics

These innovative companies are developing revolutionary blood tests that can detect cancer earlier and more accurately than ever before. Carefully selected by healthcare investment experts, this collection represents the forefront of non-invasive diagnostics poised to transform the multi-billion dollar oncology market.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Recurring revenue potential

Instrument sales can lead to steady consumable and reagent revenue, which may support long-term growth β€” though recurring sales can vary with adoption rates.

🌍

Clinical adoption focus

Wider use of Simoa assays in neurology and oncology could expand addressable markets, but adoption depends on regulatory approval and clinician uptake.

⚑

Technology edge

Ultra‑sensitive single-molecule detection differentiates the platform; however, competition and execution risks mean outcomes can be uncertain.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions